Telomere length: a cardiovascular biomarker and a novel therapeutic target

M Sagris, P Theofilis, AS Antonopoulos… - International Journal of …, 2022 - mdpi.com
Coronary artery disease (CAD) is a multifactorial disease with a high prevalence, particularly
in developing countries. Currently, the investigation of telomeres as a potential tool for the …

Pericoronary fat attenuation index—a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis

M Sagris, AS Antonopoulos, S Simantiris… - European Heart …, 2022 - academic.oup.com
Pericoronary fat attenuation index (FAI) on coronary computed tomography angiography
imaging has been proposed as a novel marker of coronary vascular inflammation with …

The anti-inflammatory effect of novel antidiabetic agents

P Theofilis, M Sagris, E Oikonomou, AS Antonopoulos… - Life, 2022 - mdpi.com
The incidence of type 2 diabetes (T2DM) has been increasing worldwide and remains one
of the leading causes of atherosclerotic disease. Several antidiabetic agents have been …

Current medical therapy and revascularization in peripheral artery disease of the lower limbs: impacts on subclinical chronic inflammation

AL Cecchini, F Biscetti, M Manzato, L Lo Sasso… - International Journal of …, 2023 - mdpi.com
Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular
disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying …

Intravascular lithotripsy in peripheral lesions with severe calcification and its use in TAVI procedure–a meta-analysis

M Sagris, N Ktenopoulos, S Soulaidopoulos… - Vasa, 2024 - econtent.hogrefe.com
Background: Heavily calcified peripheral artery lesions increase the risk of vascular
complications, constituting a severe challenge for the operator during catheter-based …

A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients—A Review PART II—Pharmacological Approach for …

M Piechocki, T Przewłocki, P Pieniążek… - Journal of Clinical …, 2024 - mdpi.com
Background: Aging is a key risk factor for atherosclerosis progression that is associated with
increased incidence of ischemic events in supplied organs, including stroke, coronary …

Secondary prevention in lower extremity artery disease patients: lipid-lowering therapy and long-term guideline adherence

L Mueller, C Engelbertz, H Reinecke… - Journal of Clinical …, 2022 - mdpi.com
Lower extremity artery disease (LEAD) affects millions of elderly patients and is associated
with elevated cardiovascular morbidity and mortality. Risk factor modification, including the …

Underutilization of guideline-recommended therapy in patients 80 years and older with peripheral artery diseases

D Messiha, O Petrikhovich, J Lortz, D Pinsdorf… - Vasa, 2023 - econtent.hogrefe.com
Background: Ageing is a major cardiovascular risk factor with detrimental changes that
culminate in a high atherosclerotic burden. Peripheral artery disease (PAD) is a major …

[HTML][HTML] Prevalent use of high-intensity statin therapy and LDL-C target attainment among PAD patients undergoing angioplasty

S Wolf, D Spirk, G Forgo, T Sebastian, D Voci… - Vasa, 2022 - econtent.hogrefe.com
Background: The global burden of peripheral arterial disease (PAD) is substantial. Reducing
the major modifiable risk factors for noncommunicable disease, including dyslipidaemia …

Adhesion Molecules as Prognostic Biomarkers in Coronary Artery Disease

M Sagris, P Theofilis, AS Antonopoulos… - Current Topics in …, 2023 - ingentaconnect.com
Atherosclerosis is a progressive disease, culminating in the production of atherosclerotic
plaques in arteries through intricate pathophysiological processes. The progression of this …